An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
Latest Information Update: 26 Sep 2023
At a glance
- Drugs Insulin lispro (Primary) ; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 23 Sep 2023 Results published in the Diabetes Therapy
- 18 Jun 2021 Status changed from active, no longer recruiting to completed.
- 04 May 2021 Status changed from recruiting to active, no longer recruiting.